Breast

An observational study of circulating tumor DNA in triple negative breast cancers with residual disease after standard neoadjuvant treatment.

Volunteers
Health Professionals

What is the purpose of this trial?

Estimate the ctDNA positivity rate in triple negative breast cancer (TNBC) patients with residual disease after completion of neoadjuvant chemotherapy and surgery.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Mariya Rozenblit

mariya.rozenblit@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Mariya Rozenblit, MD
Assistant Professor of Medicine (Medical Oncology)

Sub-Investigators

Alice Wnuk
Andrea Silber, MD
Beverly Drucker, MD, PhD
D. Barry Boyd, MD, MS
Gineesha Abraham
Javin Brita, PA
Kathleen Fenn, MD
Kerin Adelson, MD
Lajos Pusztai, MD, DPhil
Maryam Lustberg, MD, MPH
Michael Cohenuram, MD
Michelle Corso
Navid Hafez, MD, MPH
Neal Fischbach, MD
Rocco Carbone
Tara Sanft, MD

Last Updated
04/19/2024
Study HIC
#2000033096